These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 15003298

  • 1. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo.
    Wurm G, Tomancok B, Nussbaumer K, Adelwöhrer C, Holl K.
    Clin Neurol Neurosurg; 2004 Mar; 106(2):97-103. PubMed ID: 15003298
    [Abstract] [Full Text] [Related]

  • 2. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [Abstract] [Full Text] [Related]

  • 3. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, Kunze E, Matthies C, Ernestus RI, Solymosi L, Roosen K.
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM, Kassell NF, Weir BK, Haley EC, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW.
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [Abstract] [Full Text] [Related]

  • 6. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E.
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [Abstract] [Full Text] [Related]

  • 7. Plasma acrolein levels and their association with delayed ischemic neurological deficits following aneurysmal subarachnoid haemorrhage: a pilot study.
    Garrett MC, McCullough-Hicks ME, Kim GH, Komotar RJ, Kellner CP, Hahn DK, Otten ML, Rynkowski MA, Merkow MB, Starke RM, Connolly ES.
    Br J Neurosurg; 2008 Aug; 22(4):546-9. PubMed ID: 18686065
    [Abstract] [Full Text] [Related]

  • 8. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
    Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP.
    Neurosurgery; 2008 Feb; 62(2):422-7; discussion 427-30. PubMed ID: 18382320
    [Abstract] [Full Text] [Related]

  • 9. Role of brain natriuretic peptide in cerebral vasospasm.
    Sviri GE, Shik V, Raz B, Soustiel JF.
    Acta Neurochir (Wien); 2003 Oct; 145(10):851-60; discussion 860. PubMed ID: 14577006
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM.
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [Abstract] [Full Text] [Related]

  • 11. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M, Capelle HH, Münch E, Thomé C, Fiedler F, Schmiedek P, Vajkoczy P.
    Acta Neurochir (Wien); 2007 Dec; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [Abstract] [Full Text] [Related]

  • 12. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F, Escribá A, Maluenda MP, López Rubio M, Margalet I, Lezana A, Gallego J, Ribera JM.
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [Abstract] [Full Text] [Related]

  • 13. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage.
    Munakata A, Ohkuma H, Nakano T, Shimamura N, Asano K, Naraoka M.
    Neurosurgery; 2009 Mar; 64(3):423-8; discussion 428-9. PubMed ID: 19240603
    [Abstract] [Full Text] [Related]

  • 14. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
    Marlovits S, Striessnig G, Schuster R, Stocker R, Luxl M, Trattnig S, Vécsei V.
    Arthroscopy; 2007 Jul; 23(7):696-702. PubMed ID: 17637403
    [Abstract] [Full Text] [Related]

  • 15. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A.
    Cerebrovasc Dis; 2016 Jul; 42(1-2):97-105. PubMed ID: 27070952
    [Abstract] [Full Text] [Related]

  • 16. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C, Zhao S, Zang Y, Zhao W, Song Q, Feng S, Hu L, Gu F.
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [Abstract] [Full Text] [Related]

  • 17. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial.
    Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J, Lassila R.
    J Neurosurg; 2003 Dec; 99(6):953-9. PubMed ID: 14705720
    [Abstract] [Full Text] [Related]

  • 18. Cerebrovascular carbon dioxide reactivity and delayed cerebral ischemia after subarachnoid hemorrhage.
    Carrera E, Kurtz P, Badjatia N, Fernandez L, Claassen J, Lee K, Schmidt JM, Connolly ES, Marshall RS, Mayer SA.
    Arch Neurol; 2010 Apr; 67(4):434-9. PubMed ID: 20385909
    [Abstract] [Full Text] [Related]

  • 19. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB.
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
    [Abstract] [Full Text] [Related]

  • 20. Clazosentan: prevention of cerebral vasospasm and the potential to overcome infarction.
    Beck J, Raabe A.
    Acta Neurochir Suppl; 2011 Aug; 110(Pt 2):147-50. PubMed ID: 21125461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.